A phase IV pharmacovigilance study investigating pyronaridine/artesunate (Pyramax) granules and tablets in real-life settings

Trial Profile

A phase IV pharmacovigilance study investigating pyronaridine/artesunate (Pyramax) granules and tablets in real-life settings

Planning
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2016

At a glance

  • Drugs Artesunate/pyronaridine (Primary)
  • Indications Malaria
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Apr 2016 According to Medicines for Malaria Venture media release, this trial will be initiated in 2016.
    • 16 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top